Orchestra BioMed Holdings, Inc.

OBIO

$4.74

-4.24%

N/A-$0.21

Healthcare

Biotechnology

NASDAQ

Active Trading

Orchestra BioMed Holdings, Inc. operates as an innovative company in the biomedical sector. Its leading product candidates are BackBeat Cardiac Neuromodulation Therapy ...

Financial Highlights of OBIO

Profitability trend

Latest / TTM · 6 periods

Gross Margin

99.3%

Net Margin

-184.6%

P/E Ratio

-4.79x

n/a

Debt / Equity

2.41

n/a

Current Ratio

8.26

Dividend Yield

0.0%

Understanding

TTM —

High debt to equity

Interest coverage is weak

Financial highlights

Latest / TTM · 6 periods

Snapshot

Latest / TTM: 2026-09-04

Gross Margin

99.3%

Net Margin

-184.6%

P/E Ratio

-4.79x

Debt / Equity

2.41

Profitability

Profitability table

Metric	2021	2022	2023	2024	2025	2026
Gross MarginGross profit as a percentage of revenue.	125.4%	90.9%	93.3%	92.3%	99.4%	—
Operating MarginOperating income as a percentage of revenue.	2787.6%	-924.3%	-1866.2%	-2437.5%	-154.7%	—
Net MarginNet income as a percentage of revenue.	2943.0%	-951.3%	-1779.7%	-2313.3%	-157.4%	—
EBITDA MarginEBITDA divided by revenue.	2801.3%	-945.0%	-1769.3%	-2301.6%	-153.0%	—
Pre-tax MarginPre-tax profit as a percentage of revenue.	2943.0%	-951.3%	-1779.7%	-2313.3%	-157.4%	—

Liquidity & leverage

Liquidity & leverage table

Metric	2021	2022	2023	2024	2025	2026
Current RatioCurrent assets divided by current liabilities.	0.92	4.56	7.95	4.27	6.45	—
Quick RatioLiquid assets divided by current liabilities.	0.92	4.55	7.94	4.26	6.43	—
Cash RatioCash and equivalents divided by current liabilities.	0.81	1.07	2.73	1.37	2.07	—
Debt / AssetsDebt as a share of total assets.	41.9%	12.4%	1.8%	21.7%	13.9%	—
Debt / EquityDebt compared with shareholder equity.	-0.08	0.23	0.02	0.50	0.25	—

Operating efficiency

Operating efficiency table

Metric	2021	2022	2023	2024	2025	2026
Receivables TurnoverHow often receivables are collected in a year.	-6.46x	36.80x	27.88x	28.67x	352.44x	—
Inventory TurnoverHow often inventory is sold in a year.	2.93x	1.17x	1.27x	1.18x	0.61x	—
Payables TurnoverHow often payables are paid in a year.	0.10x	0.08x	0.06x	0.04x	0.03x	—
Asset TurnoverRevenue generated per dollar of assets.	-0.06x	0.04x	0.03x	0.03x	0.29x	—
Working Capital TurnoverRevenue generated per dollar of working capital.	-0.07x	0.11x	0.04x	0.04x	0.46x	—

Valuation ratios

Valuation ratios table

Metric	2021	2022	2023	2024	2025	2026
P/E RatioPrice paid for each dollar of earnings.	-544.86x	-7.56x	-6.17x	-2.41x	-3.74x	—
P/B RatioPrice paid for each dollar of book value.	-2.89x	4.84x	4.46x	4.47x	3.13x	—
P/S RatioPrice paid for each dollar of sales.	-263.60x	71.95x	109.91x	55.83x	5.92x	—
P/FCF RatioPrice paid for each dollar of free cash flow.	-10.46x	-8.51x	-6.57x	-2.90x	-4.01x	—
Dividend YieldAnnual dividend divided by current share price.	0.0%	0.0%	0.0%	0.0%	0.0%	—

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer